Orhan Ayyıldız

1.1k total citations
64 papers, 657 citations indexed

About

Orhan Ayyıldız is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Orhan Ayyıldız has authored 64 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 17 papers in Genetics and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Orhan Ayyıldız's work include Chronic Lymphocytic Leukemia Research (7 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Platelet Disorders and Treatments (6 papers). Orhan Ayyıldız is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Platelet Disorders and Treatments (6 papers). Orhan Ayyıldız collaborates with scholars based in Türkiye, Iran and United States. Orhan Ayyıldız's co-authors include Abdullah Altıntaş, Timuçin Çil, Semir Paşa, Mehmet Rami Helvacı, Abdurrahman Işıkdoğan, Naci Tiftik, Mehmet Ali Gündoğdu, Ramazan Danış, Nilüfer Okur and Kaplan Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Infectious Diseases and Journal of Neuro-Oncology.

In The Last Decade

Orhan Ayyıldız

57 papers receiving 626 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Orhan Ayyıldız Türkiye 16 324 179 93 89 86 64 657
Aamer Aleem Saudi Arabia 14 320 1.0× 250 1.4× 59 0.6× 65 0.7× 59 0.7× 76 554
Jyh‐Pyng Gau Taiwan 14 277 0.9× 95 0.5× 120 1.3× 93 1.0× 51 0.6× 74 659
Nilgün Sayınalp Türkiye 16 511 1.6× 203 1.1× 142 1.5× 39 0.4× 127 1.5× 84 875
Guillermo J. Ruiz‐Delgado Mexico 17 616 1.9× 203 1.1× 180 1.9× 143 1.6× 42 0.5× 130 953
Liang-Tsai Hsiao Taiwan 15 199 0.6× 77 0.4× 65 0.7× 143 1.6× 43 0.5× 50 894
Gülersu İrken Türkiye 14 296 0.9× 105 0.6× 105 1.1× 35 0.4× 51 0.6× 64 631
Eugenia Biguzzi Italy 18 540 1.7× 120 0.7× 85 0.9× 31 0.3× 63 0.7× 50 929
Pascal Chaı̈bi France 12 147 0.5× 83 0.5× 66 0.7× 60 0.7× 53 0.6× 33 528
Katharine A. Downes United States 14 270 0.8× 56 0.3× 30 0.3× 49 0.6× 94 1.1× 26 692
Ken Kaito Japan 10 358 1.1× 83 0.5× 57 0.6× 36 0.4× 37 0.4× 45 584

Countries citing papers authored by Orhan Ayyıldız

Since Specialization
Citations

This map shows the geographic impact of Orhan Ayyıldız's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orhan Ayyıldız with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orhan Ayyıldız more than expected).

Fields of papers citing papers by Orhan Ayyıldız

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orhan Ayyıldız. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orhan Ayyıldız. The network helps show where Orhan Ayyıldız may publish in the future.

Co-authorship network of co-authors of Orhan Ayyıldız

This figure shows the co-authorship network connecting the top 25 collaborators of Orhan Ayyıldız. A scholar is included among the top collaborators of Orhan Ayyıldız based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orhan Ayyıldız. Orhan Ayyıldız is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ayyıldız, Orhan, et al.. (2024). A CASE OF THROMBOTIC THROMBOCYTOPENIC PURPURA RELATED TO MALIGNITY AND CHEMOTHERAPY. Hematology Transfusion and Cell Therapy. 46. S65–S65.
2.
Helvacı, Mehmet Rami, et al.. (2019). Body Mass and Blood Pressure. World Family Medicine Journal/Middle East Journal of Family Medicine. 17(1). 36–40. 16 indexed citations
3.
Helvacı, Mehmet Rami, Orhan Ayyıldız, & Mehmet Ali Gündoğdu. (2018). Hyperlipoproteinemias May Actually Be Acute Phase Reactants in the Plasma. World Family Medicine Journal/Middle East Journal of Family Medicine. 16(1). 7–10. 11 indexed citations
4.
Helvacı, Mehmet Rami, Orhan Ayyıldız, & Mehmet Ali Gündoğdu. (2018). Excess Weight or Smoking. World Family Medicine Journal/Middle East Journal of Family Medicine. 16(10). 14–19. 5 indexed citations
5.
Aydoğdu, İsmet, Mehmet Şencan, Ali Kaya, et al.. (2017). Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience. Hematological Oncology. 36(1). 116–120. 4 indexed citations
6.
Helvacı, Mehmet Rami, et al.. (2017). White Coat Hypertension May Be an Initial Sign of an Accelerated Atherosclerotic Process. 10(2). 27–32. 1 indexed citations
7.
Helvacı, Mehmet Rami, Orhan Ayyıldız, & Mustafa Cem Algın. (2017). Alanine Aminotransferase Indicates Excess Weight and Dyslipidemia. World Family Medicine Journal/Middle East Journal of Family Medicine. 15(9). 13–17. 1 indexed citations
8.
Helvacı, Mehmet Rami, Orhan Ayyıldız, & Mustafa Cem Algın. (2017). Irritable Bowel Syndrome and Smoking. World Family Medicine Journal/Middle East Journal of Family Medicine. 15(10). 7–11. 3 indexed citations
9.
Helvacı, Mehmet Rami, et al.. (2016). Red Blood Cell Supports in Severe Clinical Conditions in Sickle Cell Diseases. World Family Medicine Journal/Middle East Journal of Family Medicine. 14(5). 11–18. 12 indexed citations
10.
Paşa, Semir, Abdullah Altıntaş, Cemıl Tümer, et al.. (2010). Prothrombin time, activated thromboplastin time, fibrinogen and D-dimer levels and von-Willebrand activity of patients with sheehan’s syndrome and the effect of hormone replacement therapy on these factors. 20(4). 212–219. 6 indexed citations
11.
Yalçın, Kendal & Orhan Ayyıldız. (2009). Karaciğer sirozunda hemostatik bozukluklar. 36(2). 127–133. 1 indexed citations
12.
Paşa, Semir, Abdullah Altıntaş, Timuçin Çil, et al.. (2008). Two cases of bacterial meningitis accompanied by thalidomide therapy in patients with multiple myeloma: is thalidomide associated with bacterial meningitis?. International Journal of Infectious Diseases. 13(1). e19–e22. 4 indexed citations
13.
Paşa, Semir, et al.. (2008). A case of essential mixed cryoglobulinemia and associated acquired von-Willebrand disease treated with rituximab. Journal of Thrombosis and Thrombolysis. 27(2). 220–222. 6 indexed citations
14.
Paşa, Semir, Abdullah Altıntaş, Timuçin Çil, Ramazan Danış, & Orhan Ayyıldız. (2008). The efficacy of rituximab in patients with splenectomized refractory chronic idiopathic thrombocythopenic purpura. Journal of Thrombosis and Thrombolysis. 27(3). 329–333. 13 indexed citations
15.
Altıntaş, Abdullah, et al.. (2007). Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura. Journal of Thrombosis and Thrombolysis. 24(2). 163–168. 58 indexed citations
16.
Tiftik, Naci, et al.. (2004). The importance of CD7 and CD56 antigens in acute leukaemias. International Journal of Clinical Practice. 58(2). 149–152. 23 indexed citations
17.
Işıkdoğan, Abdurrahman, et al.. (2003). Hepatitis C Virus in Patients with Non-Hodgkin's Lymphoma in Southeastern Anatolia Region of Turkey: A Prospective Case-control Study of 119 Patients. Leukemia & lymphoma. 44(10). 1745–1747. 13 indexed citations
18.
19.
20.
Işıkdoğan, Abdurrahman, et al.. (2002). Hodgkin's Disease Variant of Richter's Transformation. Medical Oncology. 19(2). 109–112. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aamer Aleem Breakdown of academic impact, for papers by Jyh‐Pyng Gau Breakdown of academic impact, for papers by Nilgün Sayınalp Breakdown of academic impact, for papers by Guillermo J. Ruiz‐Delgado Breakdown of academic impact, for papers by Liang-Tsai Hsiao Breakdown of academic impact, for papers by Gülersu İrken Breakdown of academic impact, for papers by Eugenia Biguzzi Breakdown of academic impact, for papers by Pascal Chaı̈bi Breakdown of academic impact, for papers by Katharine A. Downes Breakdown of academic impact, for papers by Ken Kaito
Rankless by CCL
2026